Cardinal Capital Management Regeneron Pharmaceuticals, Inc. Transaction History
Cardinal Capital Management
- $634 Million
- Q1 2025
A detailed history of Cardinal Capital Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cardinal Capital Management holds 8,036 shares of REGN stock, worth $4.7 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
8,036
Previous 7,871
2.1%
Holding current value
$4.7 Million
Previous $5.61 Million
9.1%
% of portfolio
0.8%
Previous 0.89%
Shares
26 transactions
Others Institutions Holding REGN
# of Institutions
1,490Shares Held
87.1MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.44 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.95 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.13 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.83 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.77 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...